A Rare Vascular Complication Caused by Autologous Fat Facial Filler

2020 ◽  
Vol 44 (6) ◽  
pp. 2323-2325
Author(s):  
Aiping Li ◽  
Jianwen Yang ◽  
Xiang Ren ◽  
Zhiwen Zhou ◽  
Wei Wei ◽  
...  
2019 ◽  
Vol 11 (2) ◽  
pp. 150-156 ◽  
Author(s):  
Saranya Khunkhet ◽  
Teerapong Rattananukrom ◽  
Wilai Thanasarnaksorn ◽  
Poonkiat Suchonwanit

Alopecia secondary to facial filler injections is a highly unusual sequela. Only 2 cases of hyaluronic acid-induced alopecia have been reported to date. Accumulating evidence suggests vascular compromise as its etiology, which can be accidental intravascular injection or external compression by overfilled materials. We hereby present, to the best of our knowledge, the first case of localized nonscarring and scarring alopecia secondary to autologous fat grafting and review the literature regarding filler-induced alopecia.


2010 ◽  
Vol 41 (9) ◽  
pp. 23
Author(s):  
DAMIAN McNAMARA
Keyword(s):  

JAMA ◽  
1967 ◽  
Vol 200 (1) ◽  
pp. 72-73 ◽  
Author(s):  
P. H. Guilfoil

VASA ◽  
2018 ◽  
Vol 47 (2) ◽  
pp. 119-124 ◽  
Author(s):  
Artur I. Milnerowicz ◽  
Aleksandra A. Milnerowicz ◽  
Marcin Protasiewicz ◽  
Wiktor Kuliczkowski

Abstract. Background: Effectiveness of vascular closure devices during endovascular procedures requiring a direct puncture of a vascular prosthesis placed in the inguinal region is unknown. Patients and methods: The retrospective analysis included 134 patients with a history of polyethylene terephthalate (PETE) graft implantation in the inguinal region. In 20 (15 %) patients, haemostasis was achieved with manual compression, in 21 (16 %) with the StarClose™, and in 93 (69 %) with the AngioSeal™ device. Results: The incidence of vascular complications in the manual compression group was higher (at a threshold of statistical significance) than in the device closure group (45.0 vs. 24.5 %, p = 0.059). The difference was considered statistically significant when manual compression was compared with the AngioSeal™ closure group (45.0 vs. 13.9 %, p < 0.01). The vascular complication rate in the StarClose™ group was significantly higher than in the AngioSeal™ group (71.4 vs. 13.9 %, p < 0.000001). While haematomas were the only vascular complications observed after application of AngioSeal™, both haematomas and pseudoaneurysms were found in the StarClose™ group. Conclusions: The AngioSeal™ vascular closure device provides better local haemostasis than the StarClose™ device or manual compression during endovascular interventions requiring a direct puncture of PETE grafts


Sign in / Sign up

Export Citation Format

Share Document